Abbott Laboratories (ABT)
Abbott Laboratories Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 1.242B | 1.619B | 303.18M | 1.943B | 863.82M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 743.27M | 648.43M | 838.39M | 811.41M | 745.67M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 347.34M | 604.06M | 67.84M | 248.96M | 275.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 1.091B | 1.252B | 906.22M | 1.060B | 1.021B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | -1.402B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Total Changes in Assets/Liabilities | -38.20M | -318.98M | -245.82M | 222.13M | 343.74M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | -69.60M | -1.151B | 2.091B | -722.13M | -217.88M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | 2.225B | 1.401B | 3.054B | 2.503B | 2.011B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -453.33M | -274.74M | -452.00M | -372.96M | -391.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | -670.85M | 0.00 | -485.00M | -187.50M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Investments | -3.900B | 1.632B | 1.932B | -1.109B | -1.917B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | 11.15M | 6.928M | -3.199M | 1.875B | 7.804M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -5.013B | 1.364B | 992.00M | 205.59M | -2.301B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 1.345B | -1.181B | -1.964B | -727.58M | -104.37M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | -300.41M | 648.72M | 47.22M | 91.81M | 104.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | -758.55M | -752.09M | -751.63M | -750.41M | -683.97M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 286.07M | -1.285B | -2.668B | -1.386B | -684.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 34.70M | 282.52M | -406.02M | 14.30M | 66.20M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -2.467B | 1.764B | 972.28M | 1.337B | -908.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 6.813B | 3.648B | 6.813B | 5.049B | 4.077B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 4.346B | 6.813B | 5.049B | 4.077B | 2.740B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
